1 event found.
Events
ALKtALK: Dr. Alex Drilon
New Data, New Directions: Neladalkib (NVL-655) and Precision Oncology in ALK-positive Cancer Alexander Drilon, MD, is a thoracic oncologist and Chief of the Early Drug Development Service at Memorial Sloan Kettering Cancer […]

